drugset / Trial / NCT05811247
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
Timeline
- Start
- 2023-08-28
- Primary completion
- 2025-05-07
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD109 | Unknown | — | Oral |